Psychopharmacology and Psychiatry Updates Understanding TMS in OCD: Evidence and Practice
Apr 1, 2025
Transcranial Magnetic Stimulation (TMS) is gaining attention as a treatment for Obsessive-Compulsive Disorder (OCD). Discover how FDA-approved devices are tailored specifically for OCD and the unique protocols that require anxiety triggers before each session. Learn about the different brain regions targeted by TMS for OCD compared to depression. The discussion also emphasizes the importance of combining TMS with psychotherapy to maximize treatment effectiveness. Patient outcomes are highlighted, showcasing the potential of TMS as a groundbreaking therapy.
AI Snips
Chapters
Transcript
Episode notes
TMS Devices for OCD
- Three TMS devices are FDA-approved for OCD: Brainsway, MagVenture, and Neurostar.
- These devices are approved as adjunctive treatment, not monotherapy.
Brainsway TMS Protocol
- The Brainsway TMS device for OCD uses the H7 coil, targeting the dorsal medial prefrontal cortex.
- Treatment involves 29 sessions over six weeks, preceded by provoking OCD symptoms.
Provoking OCD Symptoms
- Before each TMS session, provoke the patient's OCD symptoms to a distress level of 4-7/10.
- This "psychotherapy part" is why TMS for OCD is considered an adjunctive treatment.